Malvinder & Shivinder Singh Net Worth: Malvinder & Shivinder Singh are Indian brothers and businessmen who have a net worth of $2.2 billion, a fortune that the two share. Malvinder Singh is best known for being a former chairman and CEO of Ranbaxy Laboratories, an Indian unit of Japanese drugmaker Daiichi Sankyo. Since Ranbaxy was founded by the siblings' grandfather and then owned by their father, Malvinder and Shivinder inherited their family's 33.5% stake in Ranbaxy in 1999 upon the death of their father. They decided to sell their inheritance in 2008 for $2 billion, after which Malvinder resigned as Chairman and CEO in the company. Aside from their portion in Ranbaxy, they have been also shedding some international assets to focus on their home market in India. To date, they have sold an Australian dental company, a Hong Kong health care firm and a Vietnamese medical chain, for a combined $700 million. They also reduced their share in Religare in order to comply with the law on minimum public shareholding and are keen to start a bank together. Today, the Singh sibling duo is in charge of the hospital chain Fortis Healthcare and financial services company Religare, among other assets.
All net worths are calculated by applying a proprietary algorithm. The results are then fact checked and confirmed by a team of editors. We scan all publicly available data and resources and work diligently to ensure that our numbers are the most accurate and up to date net worth data you will find anywhere on the internet.